Navigation Links
Preventing or reducing enlarged heart may decrease risk for diabetes
Date:10/31/2007

NEW YORK (Oct. 31, 2007) -- High-blood-pressure patients treated for enlarged heart (left ventricular hypertrophy, LVH) who have regression or prevention of LVH may also have a better chance of preventing diabetes. Led by physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, the research is published in the November Hypertension, a journal of the American Heart Association (AHA).

An estimated 20 percent of all high-blood-pressure patients, or 12 million Americans, have LVH and are at increased risk of developing diabetes.

The study reports a 38-percent reduced risk of developing diabetes for high-blood-pressure patients who demonstrated regression of LVH during treatment for high blood pressure, with a 26-percent reduced risk after adjusting for other risk factors for diabetes. The reduction in risk of diabetes was independent of treatment type and of the degree of blood pressure change in this population.

"A healthy heart is a prerequisite for the health of the body as a whole. Our previous research has shown that treating enlarged heart in high-blood-pressure patients reduces the risk for a variety of cardiovascular conditions. This new study finds an important new benefit -- namely a better chance of avoiding diabetes among patients who exhibit a reduction of their hypertrophy during treatment," says the study's principal investigator, Dr. Peter Okin, director of clinical affairs and professor of medicine in the Greenberg Division of Cardiology at Weill Cornell Medical College and attending physician at NewYork-Presbyterian/Weill Cornell.

An editorial about the study in the journal notes that "the study by Okin et al extends our knowledge and understanding of the importance of LVH reversal by showing the beneficial metabolic effects of treatment-induced regression of LVH in a large series of patients with hypertensive heart disease."

Unfortunately, for high-blood-pressure patients wh
'/>"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Preventing mental decline in the aged
2. Preventing white coat hypertension
3. Green tea beneficial in preventing osteoarthritis
4. Preventing Childhood Deaths
5. Preventing Vision Loss
6. Preventing Vision Loss
7. Preventing Colorectal Cancer
8. Preventing Prostate Cancer
9. Lycopene Can Help In Preventing Prostate Cancer
10. Heart Drug Also Effective In Preventing Specific Causes Of Death
11. Preventing cavities in children

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...re/--TheBayAreaAirQualityManagementDistrictisissui... Alert forThursday,November26,2009whichbansburn...thindoorsandoutdoors. ,, "Cold,stillweatherwill...roadbent,executiveofficeroftheAirDistrict."We,reas...borsandfellowcommunitymembersthisThanksgiving,andn...
(Date:11/25/2009)...cancer who were treated with cisplatin-based chemo...urological side effects and Raynaud-like phenomena... according to a new study published online Novembe...ute . , Marianne Brydy, M.D., of the Department ...gen, Norway, and colleagues conducted a cross-sect...
(Date:11/25/2009)... out of a collaboration between UCLA engineers and...arly 10 million Americans who suffer from peripher...ng of the arteries, peripheral arterial disease, o...rrowed arteries reduce blood flow to the limbs. Th...disease, heart attack and stroke, and its progress...
(Date:11/25/2009)...hort to draw definite conclusions, experts say, ,...- In diabetic patients with blocked coronary arter... at one year whether patients undergo bypass surge...rs report. , Bypass surgery has been the standa...rtery disease. However, less invasive approaches s...
(Date:11/25/2009)... and treatment clinics to resume Monday, Nov. 30 ...er 25, 2009 -- Centegra Health System is continuin...ots at four Centegra Primary Care (CPC) vaccinatio...rived. The clinics are at CPC sites in Huntley, Wo... as follows: ,   From 4:30 to 7:30 p.m...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
... Bias Correction of Familial Risk Estimates Incr...r Common Cancers , The relative risk of familial... account for a known potential bias in a large coh... have used the Swedish Cancer Registry and the Swe...
...espite recommendations from various groups, many h... TUESDAY, Sept. 9 (HealthDay News) -- According to... report giving formula sample packs to new moms, e... Adolescent Medicine , surveyed 1,295 hospitals in...
...EXFORD, Penn., Sept. 9 Millennium Pharmacy System...hnology enabled pharmacy,solutions to senior healt...of Richard Scardina as Chief Executive Officer. Mr...erving as an executive,with Caremark Rx, Inc., Ga...
... PHILADELPHIA - Researchers from the University o...a key step in the formation and suppression of e...east, head, and neck. By studying human tissue sam...t to contribute to the early stages of cancer deve...
...THENS, Ga., Sept. 9 ArunA Biomedical, Inc., the f... cell derived products and,services, announced tod...ion CFO, Harold "Bud" Ingalls, to its Board of Dir...arly 20 years of experience as a chief financial o...
...lan Challenges Policy-makers, Physicians, Patients...SHINGTON, Sept. 9 In an address today at,the Nati...E: MHS ) Chairman,and CEO, David B. Snow Jr. unve... problem. Unifying the strengths,of both the publi...
Other Medicine News:Health News:Also in the Sept. 9 JNCI 2Health News:Also in the Sept. 9 JNCI 3Health News:Formula Samples Hinder Breast-Feeding Efforts 2Health News:Penn researchers identify natural tumor suppressor 2Health News:ArunA Biomedical Names Harold Ingalls to its Board of Directors 2Health News:Medco CEO Unveils Pragmatic Blueprint for Health Care Reform; Reducing Costs by Upwards of $1 Trillion 2Health News:Medco CEO Unveils Pragmatic Blueprint for Health Care Reform; Reducing Costs by Upwards of $1 Trillion 3Health News:Medco CEO Unveils Pragmatic Blueprint for Health Care Reform; Reducing Costs by Upwards of $1 Trillion 4
(Date:11/25/2009)...ndsResearchGroup,Inc.releasedWave1ofits LaunchTre...syndicatedmarketresearchprojecttrackingthelaunchof...roughthefirstsixmonthsofavailability.Eachwaveofthe...ermatologistsandqualitativeinformationfromasubseto...touse,typicalpatienttypes,productperceptions,promo...
(Date:11/25/2009)...--RegadoBiosciences,aprivatelyheldcompanyleadingth...rolagents,announcedthatDavidMazzo,PhD,CEOandPresid...lthCareConferenceattheNewYorkPalaceHotelinNewYorkC...onTuesday,December1andwillincludeanoverviewoftheCo...gram,theanticoagulantsystem,REG1.Thehealthcareindu...
(Date:11/25/2009).../--SwissrayInternational,Inc.aleadingmanufacturero...odaythatitsoperationshavebeenacquiredbyaprivateSwi...smedicalimagingbrand.Theacquisitionincludedallasse...ntory.After25yearsofsuccessandgrowthSwissrayisnowp...tswithstableandsteadygrowth. ,, "Swissrayhaslon...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Swissray International Announces New Ownership 2SpectraScience Receives FDA Approval for Enhancements to WavSTAT 28R 29 Optical Biopsy System 57419 1SpectraScience Receives FDA Approval for Enhancements to WavSTAT 28R 29 Optical Biopsy System 57419 2Scars of Bullying Linger 57417 1InVitria Cell Culture Product Line to Headline PEACe 57415 1InVitria Cell Culture Product Line to Headline PEACe 57415 2
... Agennix Incorporated today announced,the publica...rial with,talactoferrin alfa in patients who had f...c renal cell carcinoma (RCC). Results from the stu...journal ,Cancer, (volume,113, number 1), demonstra...rable toxicity profile, and is a promising candida...
...innon, Founder of HEAR Music, NEW YORK, June 30 ...eamless way for people to receive music from artis...h (RED). By applying the (RED),idea to music this ...ists,and labels and buy life-saving medicine for t...founder of HEAR Music and former Vice President of...
Other Medicine Technology:Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 2Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 3Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 4Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 5(RED) to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa 2(RED) to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa 3
Streck-Kleen Concentrate Enzymatic Cleanser
Streck-CD3500 Hemoglobin/Lyse Lytic Reagent
Streck-Diluent III Plus Balanced Electrolyte Solution
Streck-Diluent IIIA Balanced Electrolyte Solution
Medicine Products: